• This record comes from PubMed

Gain-of-function EGLN1 prolyl hydroxylase (PHD2 D4E:C127S) in combination with EPAS1 (HIF-2α) polymorphism lowers hemoglobin concentration in Tibetan highlanders

. 2017 Jun ; 95 (6) : 665-670. [epub] 20170223

Language English Country Germany Media print-electronic

Document type Journal Article

Grant support
K12 HD057022 NICHD NIH HHS - United States
R01 HL138181 NHLBI NIH HHS - United States
P01 CA108671 NCI NIH HHS - United States

Links

PubMed 28233034
DOI 10.1007/s00109-017-1519-3
PII: 10.1007/s00109-017-1519-3
Knihovny.cz E-resources

UNLABELLED: Tibetans have lived at high altitude for generations and are thought to be genetically adapted to hypoxic environments. Most are protected from hypoxia-induced polycythemia, and a haplotype of EPAS1, encoding hypoxia-inducible factor (HIF-2α), has been associated with lower hemoglobin levels. We earlier reported a Tibetan-specific EGLN1 haplotype encoding PHD2 which abrogates HIF augmentation in hypoxia. We genotyped 347 Tibetan individuals from varying altitudes for both the Tibetan-specific EGLN1 haplotype and 10 candidate SNPs in the EPAS1 haplotype and correlated their association with hemoglobin levels. The effect of the EGLN1 haplotype on hemoglobin exhibited age dependency at low altitude, while at higher altitudes, it showed a trend to lower hemoglobin levels in the presence of the Tibetan-selected EPAS1 rs142764723 C/C allele. The observed gene-environment and gene-gene interactions and the moderate effect of the EGLN1 and EPAS1 haplotypes on hemoglobin indicate that other modifiers exist. It remains to be determined whether a blunting of erythropoiesis or other physiological consequences of HIF downregulation are the primary drivers of these genetic adaptations among Tibetans. KEY MESSAGE: Most Tibetans are protected from polycythemia while living in high altitude. An EGLN1 co-adapted haplotype, EGLN1 c.12C>G, c.380G>C is uniquely Tibetan. The Tibetan EPAS1 haplotype has introgressed from the Denisovan genome. While EGLN1 and EPAS1 genotypes lower Hb, this study indicates additional Hb modifiers.

See more in PubMed

Am J Physiol Regul Integr Comp Physiol. 2009 Nov;297(5):R1477-85 PubMed

J Appl Physiol (1985). 2005 Feb;98(2):598-604 PubMed

J Appl Physiol (1985). 1989 Apr;66(4):1561-9 PubMed

Science. 2010 Jul 2;329(5987):75-8 PubMed

Annu Rev Pathol. 2014;9:47-71 PubMed

Blood. 2012 Jan 19;119(3):857-60 PubMed

Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11459-64 PubMed

Am J Phys Anthropol. 1994 Nov;95(3):271-6 PubMed

Nature. 2014 Aug 14;512(7513):194-7 PubMed

J Appl Physiol (1985). 1996 Oct;81(4):1850-4 PubMed

Am J Phys Anthropol. 1998;Suppl 27:25-64 PubMed

Science. 2010 Feb 12;327(5967):883-6 PubMed

Blood Cells Mol Dis. 2014 Dec;53(4):204-10 PubMed

Am J Phys Anthropol. 1998 Jul;106(3):385-400 PubMed

Am J Hum Biol. 2001 Sep-Oct;13(5):635-44 PubMed

Pediatrics. 2015 Feb;135(2):211-2 PubMed

Clin Chem. 2004 Jul;50(7):1156-64 PubMed

Mol Cell. 2008 May 23;30(4):393-402 PubMed

Hum Genet. 2012 Apr;131(4):527-33 PubMed

High Alt Med Biol. 2005 Summer;6(2):147-57 PubMed

PLoS Genet. 2010 Sep 09;6(9):e1001116 PubMed

Am J Phys Anthropol. 1994 Feb;93(2):189-99 PubMed

Nat Genet. 2014 Sep;46(9):951-6 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...